Our mission is to provide the healthcare professionals with the pharmacogenetic, and clinical algorithm based personalised therapy to calculate the warfarin dose based on the individual patients’ BMI, comorbidity status (includes only diabetes and/or hypothyroidism), and SNP genotype (VKORC1, CYP2C9*2 and CYP2C9*3).